Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
The caudate nucleus from examples of Alzheimer's disease (mean age 68, range 51-77 yr) had a mean wet weight and total protein content that were significantly lower than control. Biochemical markers of various specific nerve cells were determined. These are thought to reflect intrinsic choliner...
Κύριοι συγγραφείς: | Pearce, B, Palmer, A, Bowen, D, Wilcock, G, Esiri, M, Davison, A |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
1984
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
ανά: Bowen, D, κ.ά.
Έκδοση: (1983) -
The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry.
ανά: Wilcock, G, κ.ά.
Έκδοση: (1983) -
Reduced GLP-1R availability in the caudate nucleus with Alzheimer’s disease
ανά: Emma Barrett, κ.ά.
Έκδοση: (2024-06-01) -
TRPV4 mRNA is elevated in the caudate nucleus with NPH but not in Alzheimer’s disease
ανά: Hunter White, κ.ά.
Έκδοση: (2022-11-01) -
Interpretive monitoring in the caudate nucleus
ανά: Marianna Yanike, κ.ά.
Έκδοση: (2014-11-01)